Liver Fibrosis Assessment in Cases of Chronic Hepatitis C after Direct Acting Antivirals Therapy using Aspartate Aminotransferase to Platelet Ratio Index and Transient Elastograph

Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic ‎Hepatitis C after Directly Acting Antiviral Drugs

Assessment of Fibrosis After Treatment with Direct-Acting Antiviral Drugs with or without Silymarin in Patients with Chronic Hepatitis C Related Liver Disease

Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients

The Fibrosis-Cirrhosis Index (FCI) for Staging of Liver Fibrosis in Chronic Hepatitis C

Non-Invasive Markers for Liver Fibrosis in Chronic HCV Patients

Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents (DAAs)

HEPATIC ELASTOGRAPHY AND FIB-4 SCORE VERSUS LIVER BIOPSY FOR ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HCV PATIENTS

Can Fibrogenesis Markers Reflect Early Hepatic Histopathology in Chronic Hepatitis C?

Evaluation of Fibrosis Regression Using FIB-5 Score in HCV and HBV Positive Patients after Treatment and Virus Suppression Respectively.